Skip to main content
. Author manuscript; available in PMC: 2020 May 1.
Published in final edited form as: Mod Pathol. 2019 Nov 1;33(4):648–656. doi: 10.1038/s41379-019-0398-2

Table 1:

Clinicopathologic Features of the Pancreatobiliary Neoplasms with PRKACA Fusions

Case Age/Sex Initial Presentation Pathology Diagnosis Clinical Follow-up
Intraductal Component Invasive Component Metastasis
1 63/M 7 cm mass in head of the pancreas IOPN Invasive adenocarcinoma with mucinous and oncocytic features Not applicable No follow up data available
2 47/M 10 cm cystic mass in caudate lobe of liver IOPN of the bile ducts Invasive adenocarcinoma with oncocytic features Not applicable Recurrence after 4 years; now deceased
3 36/M 4.5 cm cystic mass in head of the pancreas IOPN Not applicable Not applicable No evidence of disease for 10 years
4 58/F Complex cystic mass in head of the pancreas IPMN, mixed oncocytic and pancreatobiliary features Minute focus of invasion with mucinous and oncocytic features Not applicable No adjuvant therapy given. No evidence of disease for 9 months
5 52/M 2.8 cm cystic mass in head of the pancreas IPMN, mixed oncocytic and gastric features Not applicable Not applicable No evidence of disease for 6 years
6 76/M Distal pancreatic mass IPMN, mixed oncocytic and pancreatobiliary features Invasive adenocarcinoma Metastatic adenocarcinoma with oncocytic features, involving liver Recurrence and liver metastases after 20 years, disease progression despite chemotherapy

IOPN: Intraductal oncocytic papillary neoplasm; IPMN: Intraductal papillary mucinous neoplasm